MVM Partners, LLC
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 15, 2025), MVM Partners, LLC reported 3 stock positions worth $78.9 million. Its top holding was Paragon 28 (FNA) at 80.4% of the portfolio, followed by Optinose (11.3%) and Mdxhealth (MDXH, 8.3%). Compared with Q4 2024, it reduced 1. The biggest sale was Paragon 28 (FNA, shares −53%).
- Most Recent 13F
- Q2 2026
- Location
- BOSTON, MA
- CIK
- 0001947083
- Portfolio Value
- $78.9M (Q1 2025)
- SEC Filing
- 0001104659-25-049372 ↗ filed May 15, 2025
Holdings Value
Holdings 3 stocks · $78.9M
| FNA Paragon 28 Inc. | 80.36% | 4,854,882 | $63.4M | Reduce -53.3% |
| OPTINOSE INC | 11.30% | 973,684 | $8.9M | No change |
| MDXH Mdxhealth | 8.34% | 4,700,457 | $6.6M | No change |
Portfolio Sells Q4 2024 → Q1 2025
| FNA Paragon 28 Inc. | Reduce -53.3% | 80.36% | −5.65 |
Portfolio Buys Q4 2024 → Q1 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 1 | $1.9M | MDXH |
| Q1 2026 | 1 | $10.8M | MDXH |
| Q4 2025 | 1 | $16.8M | MDXH |
| Q3 2025 | 1 | $21.8M | MDXH |
| Q2 2025 | 1 | $10.3M | MDXH |
| Q1 2025 | 3 | $78.9M | FNA, OPTINOSE INC, MDXH |
| Q4 2024 | 3 | $124.4M | FNA, MDXH, OPTINOSE INC |
| Q3 2024 | 3 | $91.7M | FNA, MDXH, OPTINOSE INC |
| Q2 2024 | 3 | $99.9M | FNA, OPTINOSE INC, MDXH |
| Q1 2024 | 3 | $167.1M | FNA, OPTINOSE INC, MDXH |